Literature DB >> 20347012

Nuclear ferritin: A new role for ferritin in cell biology.

Ahmed A Alkhateeb1, James R Connor.   

Abstract

BACKGROUND: Ferritin has been traditionally considered a cytoplasmic iron storage protein. However, several studies over the last two decades have reported the nuclear localization of ferritin, specifically H-ferritin, in developing neurons, hepatocytes, corneal epithelial cells, and some cancer cells. These observations encouraged a new perspective on ferritin beyond iron storage, such as a role in the regulation of iron accessibility to nuclear components, DNA protection from iron-induced oxidative damage, and transcriptional regulation. SCOPE OF REVIEW: This review will address the translocation and functional significance of nuclear ferritin in the context of human development and disease. MAJOR
CONCLUSIONS: The nuclear translocation of ferritin is a selective energy-dependent process that does not seem to require a consensus nuclear localization signal. It is still unclear what regulates the nuclear import/export of ferritin. Some reports have implicated the phosphorylation and O-glycosylation of the ferritin protein in nuclear transport; others suggested the existence of a specific nuclear chaperone for ferritin. The data argue strongly for nuclear ferritin as a factor in human development and disease. Ferritin can bind and protect DNA from oxidative damage. It also has the potential of playing a regulatory role in transcription. GENERAL SIGNIFICANCE: Nuclear ferritin represents a novel new outlook on ferritin functionality beyond its classical role as an iron storage molecule. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347012     DOI: 10.1016/j.bbagen.2010.03.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study.

Authors:  Marta Kalousová; Tomáš Krechler; Marie Jáchymová; Aleš A Kuběna; Aleš Zák; Tomáš Zima
Journal:  Tumour Biol       Date:  2012-08-10

Review 2.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

Review 3.  Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation.

Authors:  Seema Patel
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-28       Impact factor: 4.806

Review 4.  Potentiation of hydrogen peroxide toxicity: From catalase inhibition to stable DNA-iron complexes.

Authors:  Tulip Mahaseth; Andrei Kuzminov
Journal:  Mutat Res Rev Mutat Res       Date:  2016-08-30       Impact factor: 5.657

5.  Screening, identification of prostate cancer urinary biomarkers and verification of important spots.

Authors:  Huijun Zhao; Xuhong Zhao; Ting Lei; Man Zhang
Journal:  Invest New Drugs       Date:  2019-01-04       Impact factor: 3.850

Review 6.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

7.  Potential Role of H-Ferritin in Mitigating Valvular Mineralization.

Authors:  Katalin Éva Sikura; László Potor; Tamás Szerafin; Abolfazl Zarjou; Anupam Agarwal; Paolo Arosio; Maura Poli; Zoltán Hendrik; Gábor Méhes; Melinda Oros; Niké Posta; Lívia Beke; Ibolya Fürtös; György Balla; József Balla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

8.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

9.  The iron metallome in eukaryotic organisms.

Authors:  Adrienne C Dlouhy; Caryn E Outten
Journal:  Met Ions Life Sci       Date:  2013

10.  Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma.

Authors:  Pınar Cömert; Abdulkerim Yıldız; Murat Yıldırım; Hacer Berna Afacan Öztürk; Çiğdem Pala; Murat Albayrak; Meltem Aylı
Journal:  Indian J Hematol Blood Transfus       Date:  2019-08-06       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.